Forest Labs (FRX) Shares Tick Higher Following Headline of FDA Approval for Chronic Lung Disease Treatment

Go back to Forest Labs (FRX) Shares Tick Higher Following Headline of FDA Approval for Chronic Lung Disease Treatment